VulnerabilityModified
CVE-2017-12721
An Improper Certificate Validation issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6.
MEDIUM 5.9EPSS 0.67%
Does this matter?
Lower severity and a low EPSS score (0.67%). Track it; it rarely justifies an emergency change on its own.
Description
An Improper Certificate Validation issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The pump does not validate host certificates, leaving the pump vulnerable to a man-in-the-middle (MITM) attack.
- CVSS 3.0
- 5.9 MEDIUMCVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N
- EPSS
- 0.67% probability · 50th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-295
- Affected
- smiths-medical/medfusion 4000 wireless syringe infusion pump
- Source
- ics-cert@hq.dhs.gov
References
- http://www.securityfocus.com/bid/100665Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02AThird Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/100665Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02AThird Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.